Reducing Pre-Analytical Errors: Strengthening Quality and Patient Safety in Laboratory Services

Abstract

Introduction

The text highlights the critical role of laboratory medicine in healthcare and emphasizes that the pre-analytical phase remains the most error-prone stage of laboratory testing despite advancements in analytical technologies. Errors occurring before sample analysis can negatively impact patient safety, delay diagnosis, increase healthcare costs, and reduce confidence in laboratory services.

Among pre-analytical errors, hemolysis and specimen rejection are the most common and preventable problems. Specimen rejection may result from hemolyzed samples, clotted specimens, incorrect containers, mislabeling, insufficient sample volume, delayed processing, or contamination. Hemolysis, caused by the rupture of red blood cells and release of intracellular contents into the sample, is particularly significant because it can alter laboratory results and compromise diagnostic accuracy.

Hemolyzed specimens can affect the reliability of important tests such as potassium, coagulation studies, liver enzymes, magnesium, and troponin measurements. The consequences include delayed treatment decisions, prolonged turnaround times, increased workload for healthcare staff, repeated blood collection procedures, patient dissatisfaction, and higher operational costs. Therefore, reducing hemolysis is an important patient safety and quality improvement objective.

The text identifies several preventable causes of hemolysis, including poor venipuncture techniques, inappropriate needle selection, prolonged tourniquet application, vigorous mixing of collection tubes, improper transportation, delayed processing, inconsistent staff competency, and poor adherence to standard operating procedures. Effective communication between laboratory and clinical personnel is also essential for minimizing errors.

To address these challenges, a six-month quality improvement project was implemented with the goal of reducing specimen rejection rates from 3% to below 1%. The project utilized quality management tools such as the Plan-Do-Study-Act (PDSA) cycle, Fishbone Diagram, and Six Sigma DMAIC methodology. Key interventions included data analysis, root cause identification, staff training, policy reinforcement, educational materials, performance monitoring, feedback sharing, and ensuring adequate supplies.

The initiative achieved measurable reductions in specimen rejection rates, demonstrating that structured, multidisciplinary quality improvement strategies can significantly enhance laboratory performance. A major lesson learned was the importance of continuous staff education, competency assessment, regular feedback, and ongoing monitoring to sustain improvements and ensure reliable laboratory results.

Conclusion

Pre-analytical errors continue to represent a major challenge in laboratory medicine, with hemolysis being one of the most common yet preventable causes of specimen rejection. Through structured quality improvement initiatives, healthcare organizations can significantly reduce laboratory errors, improve patient safety, and enhance operational efficiency. Sustainable improvement depends on standardized procedures, continuous staff competency development, proactive monitoring, and strong teamwork across departments. As laboratories continue to evolve, maintaining focus on pre-analytical quality will remain essential for achieving excellence in patient care. Ultimately, every accurate laboratory result begins with a high-quality specimen making pre-analytical excellence the true foundation of reliable healthcare delivery.

Copyright

Copyright © 2026 Aarathy Radhakrishnan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.